Fauci Given $1 Million Award for 'Defending Science'
TUESDAY, Feb. 16, 2021 -- Anthony Fauci, M.D., director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), has been awarded a $1 million prize for "defending science" and advocating for vaccines during the COVID-19 pandemic.
The prize from the Dan David Foundation in Israel was announced Monday, the Associated Press reported.
Fauci, who has been NIAID director since 1984 and is President Joe Biden's chief medical adviser, was praised for "courageously defending science in the face of uninformed opposition during the challenging COVID crisis," according to a statement from the private foundation. It also noted that Fauci, 80, deserved recognition for a lifetime of leadership on HIV research and AIDS relief, the AP reported.
"As the COVID-19 pandemic unraveled, [Fauci] leveraged his considerable communication skills to address people gripped by fear and anxiety and worked relentlessly to inform individuals in the United States and elsewhere about the public health measures essential for containing the pandemic's spread," the foundation's awards committee said, praising Fauci for "speaking truth to power in a highly charged political environment."
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...
MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...
MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.